why choose us

First received: February 9, 2023

Clinical Trial: Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line

Study Status: Completed

Recruit Status: Completed

Condition: Chronic Myeloid Leukemia

Study Type: Observational


Official Title: Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line - a Non-interventional Study on the Assessment of Deep Molecular Response in CML Patients in Daily Routine.

Brief Summary: This is a non-interventional observational study within the routine chronic myeloid leukemia treatment practice; no further tests were required apart from the assessments routinely performed for Chronic myeloid leukemia patients treated with nilotinib.

Read more